Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death

Journal of Cellular Physiology

Volumn 168, Issue 3, 1996, Pages 499-509

  Wu, Yuli ^a   Tewari, Manorama ^a   Cui, Shijun ^a   Rubin, Raphael ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOHEXIMIDE; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; CELL STRAIN 3T3; CYTOTOXICITY; DNA SYNTHESIS; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

3T3 CELLS; ANIMALS; APOPTOSIS; ARACHIDONIC ACID; CYCLOHEXIMIDE; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR I; MICE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN SYNTHESIS INHIBITORS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029744687     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K     Document Type: Review

References (61)

1. v-src Kinase overexpression leads to cellular resistance to the antiproliferative effects of tumor necrosis factor. FEBS Lett., 345:219-224.
2. Aggarwal, B.B., Pocsik, E., Totpal, K., and Ali-Osman, F. (1995) Suppression of antiproliferative effects of tumor necrosis factor by transfection of cells with human platelet-derived growth factor B/ c-sis gene. FEBS Lett., 357:1-6.
3. Baker J., Liu, J.P., Robertson, E., and Efstratiadis, A. (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75:73-82.
4. Barres, B.A., Hart, I.K., Coles, H.S.R., Burne, J.F., Voyvodic, J.T., Richardson, W.D., and Raff, MC. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell, 70:31-46.
5. Beck, K.D. (1994) Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Progr. Neurobiol., 44:497-516.
6. Beidler, D.R., Tewari, M., Friesen, P.D., Poirier, G., and Dixit, V.M. (1995) The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem., 270:16526-16528.
7. Bozyczko-Coyne, D., Glicksman, M.A., Prantner, J.E., McKenna, B., Connors, T., Friedman, C., Dasgupta, M., and Neff, N. (1993) IGF-1 supports the survival and/or differentiation of multiple types of central nervous system neurons. Ann. NY Acad. Sci., 692:311-313.
8. Chang, D.J., Ringold, G.M., and Heller, R.A. (1992) Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-a is mediated by lipoxygenase metabolites of arachidonic acid. Biochem. Biophys. Res. Commun., 188:538-546.
9. D'Mello, S.R., Galli, C., Ciott, T., and Calisssano, P. (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. U.S.A., 90:10989-10993.
10. Drago, J., Murphy, M., Carroll, S.M., Harvey, R.P., and Bartlett, P.F. (1991) Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc. Natl. Acad. Sci. U.S.A., 88:2199-2203.
11. Fiers, W. (1991) Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett., 285:199-212.
12. Galli, C., Meucci, O., Scorziello, A., Werge, T.M., Calissano, P., and Schettini, G. (1995) Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: The involvement of intracellular calcium and RNA synthesis. J Neurosci., 15:1172-1179.
13. Gluckman, P., Klempt, N., Guan, J., Mallard, C., Sirimanne, E., Dragunow, M., Klempt, M., Singh, K., Williams, C., and Nikolics, K. (1992) A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun., 182:593-599.
14. Gorospe, M., Kumar, S., and Baglioni, C. (1993) Tumor necrosis factor increases stability of interleukin-1 mRNA by activating protein kinase C. J. Biol. Chem., 268:6214-6220.
15. Guesdon, F., Freshney, N., Waller, R.J., Rawlinson, L., and Saklatvala, J. (1993) Interleukin 1 and tumor necrosis factor stimulate two novel protein kinases that phosphorylate the heat shock protein hsp27 and b-casein. J. Biol. Chem., 268:4236-4243.
16. Guy, G.R., Chua, S.P., Wong, N.S., Ng, S.B., and Tan, Y.H. (1991) Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J. Biol. Chem., 266:14343-14352.
17. Harrington, E.A., Bennett, M.R., Fanidi, A., and Evan, G.I. (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13:3286-3295.
18. 2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem., 268:12190-11295.
19. Heller, R.A., and Kronke, M. (1994) Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol., 126:5-9.
20. Hepburn, A., Boeynaems, J.M., Fiers, W., and Dumont, J.E. (1987) Modulation of tumor necrosis factor-α cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism. Biochem. Biophys. Res. Commun., 149:815-822.
21. Huang, S., and Terstappen, L.M.M. (1992) Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. Nature, 360:745-749.
22. Hudziak, R.M., Lewis, G.D., Shalaby, M.R., Essalu, T.E., Aggarwal, B.B., Ullrich, A., and Shepard, H.M. (1988) Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor a in NIH 3T3 cells. Proc. Natl. Acad. Sci. U.S.A., 85:5102-5106.
23. Jaattela, M., D. Wissing, D., Bauer, P.A., and Gloria, C. (1992) Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J., 11:3507-3512.
24. Jaattela, M., Benedict, M., Tewari, M., Shayman, J.A., and Dixit, V.M. (1995) Bcl-x and bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene, 10:2297-2305.
25. Klefstrom, J., Vastrik, I., Saksela, E., Valle, J., Eilers, M., and Alitalo, K. (1994) c-Myc induces cellular susceptibility to the cytotoxic action of TNF-α. EMBO J., 13:5442-5450.
26. Kolesnick, R., and Golde, D.W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell, 77:325-328.
27. Kumar, S., and Baglioni, C. (1991) Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem., 266:20960-20964.
28. Laster, S.M., Wood, J.G., and Gooding, L.R. (1988) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol, 141:2629-2634.
29. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C.T., Jr. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol. Rev., 16:143-163.
30. Liu, J.P., Baker, J., Parkins, A.S., Robertson, E.J., and Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (IGF-1) and type 1 IGF receptor (IGF1r). Cell, 75:59-72.
31. Muta, K., Krantz, S.B., Bondurant, M.C., and Wickrema, A. (1994) Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J. Clin. Invest. 94:34-43.
32. Olashaw, N.E., Van Wyk, J.J., and Pledger, W.J. (1987) Control of late Go/G1 progression and protein modification by SmC/IGF I. Am. J. Physiol., 252:C575-C579.
33. Opipari, A.W., Hu, H.M., Yabkowitz, R., and Dixit, V.M. (1992) The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem., 267:12424-12427.
34. Owen-Lynch, P.J., Wong, A.K.Y., and Whetton, A.D. (1995) v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J. Biol. Chem., 270:5956-5962.
35. Palombella, V.J., and Vilcek, J. (1989) Mitogenic and cytotoxicactions of tumor necrosis factor in BALB/c 3T3 cells. J. Biol. Chem., 264:18128-18136.
36. Pietrzkowski, Z., Lammers, R., Carpenter, G., Soderquist, A.M., Limardo, M., Phillips, P.D., Ullrich, A., and Baserga, R. (1992) Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Diff., 3:199-205.
37. Ratajczak, M.Z., Kuczynski, W.I., Onodera, K., Moore, J., Ratajczak, I., Dregenow, D.A., DeRiel, K., and Gewirtz, A. (1994) A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis. J. Clin. Invest., 94:320-327.
38. Reid, T., Ramesha, C., and Ringold, G.M. (1991) Resistance to killing by tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J. Biol. Chem., 266:16580-16586.
39. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H.L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55:2463-2469.
40. Rodriguez-Tarduchy, G., Collins, M.K.L., Garcia, I., and Lopez-Rivas, A. (1992) Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol., 149:535-540.
41. Rubin, R., and Baserga, R. (1995) The IGF-I receptor. Its role in cell proliferation, cell death, and tumorigenicity. Lab. Invest., 73:311-331.
42. Sell, C., Rubini, M., Rubin, R., Liu, J., Efstradiadis, A., and Baserga, R. (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptors. Proc. Natl. Acad. Sci. U.S.A., 90:11217-11221.
43. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. (1994) Effect of a null mutation of the type-1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14:3604-3612.
44. Sell, C., Baserga, R., and Rubin, R. (1995) Insulin-like growth factor-1 (IGF-1) and the IGF-1 receptor prevent etoposide-induced apoptosis. Cancer Res., 55:303-306.
45. Smith, C.A., Farrah, T., and Goodwin, R.G. (1994) The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell, 76:959-962.
46. Talley, A.K., Dewhurst, S., Perry, S.W., Dollard, S.C., Gummuluru, S., Fine, S.M., New, D., Epstein, L.G., Gendelman, H.E., and Gelbard, H.A. (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol., 15:2359-2366.
47. Tamm, I., and Kikuchi, T. (1990) Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent BALB/C-3T3 murine fibroblasts. J. Cell. Physiol., 143:494-500.
48. Tartaglio, L.A., Mothe, M., Hu, Y.F., and Goeddel, D.V. (1993a) Tumor necrosis factor's cytotoxic activity is signaled by the p5S TNF receptor. Cell, 73:213-216.
49. Tartaglio, L.A., Ayres, T.M., Wong, G.H.W., and Goeddel, D.V. (1993b) A novel domain within the 55 kd TNF receptor signals cell death. Cell, 74:845-853.
50. Tewari, M., and Dixit, V.M. (1995) Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270:3255-3260.
51. Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267:1456-1462.
52. Tracey, K.J., and Cerami, A. (1993) Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317-343.
53. Ullrich, A., Gray, A., Tam, A.W., Tang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Katchurea, S., Cehn, E., Jacobs, S., Francke, D., Ramachandran, J., and Fugita-Yamaguchi, Y. (1986) Insulin-like growth factor 1 receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5:2503-2512.
54. Vassalli, P. (1992) The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol., 19:411-452.
55. Vietor, J., Schwenger, P., Li, W., Schlessinger, J., and Vilcek, J. (1993) Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J. Biol. Chem., 25:18994-18999.
56. Vilcek, J., and Lee, T.H. (1991) Tumor necrosis factor: New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem., 266:7313-7316.
57. White, E., Sabbitini, P., Debbas, M., Wold, W.S.M., Kusher, D.J., and Gooding, L.R. (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol. Cell. Biol., 12:2570-2580.
58. Winston, B.W., Lange-Carter, C.A., Gardner, A.M., Johnson, G.L., and Richies, D.W.H. (1995) Tumor necrosis factor a rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. Proc. Natl. Acad. Sci. U.S.A., 92:1614-1618.
59. Wong, G.H.W., Elwell, J.H., Oberley, L.W., and Goeddel, D.V. (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 58:923-931.
60. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
61. Zumstein, P., and. Stiles, C.D. (1987) Molecular cloning of gene se-quences that are regulated by insulin-like growth factor 1. J. Biol. Chem., 262:11252-11260.